- $1.05bn
- $1.87bn
- $1.37bn
Brief: Conmed Enters First Omnibus Amendment And Increased Facility Activation Notice On May 27, 2026 - SEC Filing
Brief: Conmed Corporation Appoints Celine Martin And Jeff Mirviss To Its Board Of Directors
Medical device maker Conmed raises 2026 organic rev outlook, reaffirms EPS guidance
Brief: Micro-Tech Endoscopy To Acquire Duraclip, Precisor, And Optibite Product Lines From CONMED
U.S. STOCKS ON THE MOVE -Steel Dynamics, Aldeyra, Cencora
U.S. STOCKS ON THE MOVE-Qualcomm, Canadian Solar, Draftkings
CONMED falls after Piper Sandler downgrades to 'neutral'
U.S. STOCKS ON THE MOVE-Elbit Systems, Oklo, Janus Henderson
U.S. STOCKS ON THE MOVE-Uber, Honeywell, Delta
Piper Sandler downgrades CONMED rating to 'neutral' on lack of catalysts
U.S. RESEARCH ROUNDUP-Amazon, Estée Lauder, Ralph Lauren
Conmed Q4 sales rise 7.9%, beat analyst estimates
Brief: Conmed Q4 Adjusted EPS USD 1.43 Vs. IBES Estimate USD 1.32
Brief: Conmed Corp - Prelim Outlook FY 2026 Total Reported Revenue $1,345 Million To $1,375 Million - Presentation
Brief: CONMED Announces Chief Financial Officer Transition
Brief: Conmed Corp - Announces Exit From Gastroenterology Product Lines
U.S. RESEARCH ROUNDUP-Acadia Pharmaceuticals, Applovin Corp, Centuri Holdings
Surgical devices maker Conmed's Q3 sales rise 6.7%, slightly beating estimates
Brief: Conmed Q3 Adjusted EPS USD 1.08 Vs. IBES Estimate USD 1.05